Original Article

Levels of IGF-1 and Their Relationship with Bone Mineral Density in the Premenopausal Women with Fibromyalgia Syndrome

Volume: 23 Issue: 4, December 2008 Publish Date: December 31, 2008
Full Text PDF
Onur Armağan
Osmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Eskişehir, Türkiye image/svg+xml
Esra Sırmagül
Osmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Eskişehir, Türkiye image/svg+xml
Ayşe Ekim
Osmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Eskişehir, Türkiye image/svg+xml
Başar Sırmagül
Osmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Eskişehir, Türkiye image/svg+xml
Funda Taşçıoğlu
Osmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Eskişehir, Türkiye image/svg+xml
Cengiz Öner
Osmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Eskişehir, Türkiye image/svg+xml
Onur Armağan, Esra Sırmagül, Ayşe Ekim, Başar Sırmagül, Funda Taşçıoğlu, & Cengiz Öner. (2008). Levels of IGF-1 and Their Relationship with Bone Mineral Density in the Premenopausal Women with Fibromyalgia Syndrome. Archives of Rheumatology, 23(4), 118–123. Retrieved from https://www.archivesofrheumatology.org/index.php/pub/article/view/264
Full Text PDF

Abstract

Objective: The present study aims to compare bone mineral density (BMD) of healthy female patients with that of females with fibromyalgia syndrome (FMS), as well as to determine the relationship between insulin-like growth factor-1 (IGF-1) and BMD.

Materials and Methods: Twenty-seven premenopausal women with FMS and 21 age-matched female controls were included in the study. Body mass index (BMI), IGF-1 and osteocalcin levels were assessed for all the cases. BMD measurements of the femoral neck and lumbar spine were done by using dual-energy X-ray absorptiometry.

Results: Lomber and femoral bone mineral density were significantly lower in FMS patients compared with controls (p<0.001). Serum concentrations of IGF-1 were significantly lower in FMS than those in healthy females (p<0.01). There was a significant correlation between IGF-1 and BMD (trochanteric and lumbar spine) in FMS patients. No difference was found between the groups with respect to serum osteocalcine levels.

Conclusions: The results of the present study shows that routine BMD measurements should be done in premenopausal FMS patients, especially who have low levels of IGF-1. (Rheumatism 2008; 23: 118-23)

Similar Articles

Article Info
Published In
Journal Archives of Rheumatology
Volume / Issue Vol. 23 No. 4 (2008): The Archives of Rheumatology
Pages 118-123
History
Published Online December 31, 2008
License
Affiliations
1
Onur Armağan
Osmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Eskişehir, Türkiye
2
Esra Sırmagül
Osmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Eskişehir, Türkiye
3
Ayşe Ekim
Osmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Eskişehir, Türkiye
4
Başar Sırmagül
Osmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Eskişehir, Türkiye
5
Funda Taşçıoğlu
Osmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Eskişehir, Türkiye
6
Cengiz Öner
Osmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Eskişehir, Türkiye
Cite this Article
Onur Armağan, Esra Sırmagül, Ayşe Ekim, Başar Sırmagül, Funda Taşçıoğlu, & Cengiz Öner. (2008). Levels of IGF-1 and Their Relationship with Bone Mineral Density in the Premenopausal Women with Fibromyalgia Syndrome. Archives of Rheumatology, 23(4), 118–123. Retrieved from https://www.archivesofrheumatology.org/index.php/pub/article/view/264
Outlines